StockData
Regentis Biomaterials Ltd. logo

Regentis Biomaterials Ltd. (RGNT) stock

RGNTNYSEOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Feb 24, 2026Score 1/30
$1.14−0.08 (-6.56%)

Close on Nov 18, 2026Market cap $5.90MP/E –Yield –

Regentis Biomaterials free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Regentis Biomaterials

Regentis Biomaterials has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Regentis Biomaterials figures

See a number that looks wrong?